INVESTMENT
OPPORTUNITIES

Join us at the forefront of AI-​powered neurodegenerative disease diagnostics. Early-​
stage investment opportunity in revolutionary table tennis movement analysis
technology.

Market Opportunity

10M+

patients

with Parkinson’s disease globally

$52B

annual costs

in neurodegenerative disease care

23%

growth CAGR

projected market 2024-2028

30-40%

cost reduction

through early detection

Business Model

Flexible pricing tiers designed for sports clubs, rehabilitation centers, and healthcare
facilities

Starter

€2,700/year

  • Basic movement analysis
  • Monthly reports
  • Email support
  • Up to 50 assessments/month

RECOMMENDED

Professional

€5,400/year

  • Advanced AI analysis
  • Weekly reports
  • Dedicated support
  • Medical records integration
  • Up to 200 assessments/month

Enterprise

€9,000/year

  • Full platform access
  • Real-​time monitoring
  • Priority support
  • Custom integrations
  • White-​label options
  • Unlimited assessments

Financial Metrics

Gross Margin

80-95%

CAC Payback

0.5-1.9

months

Breakeven Point

4.3

club installations

Year 1 Revenue Target

€900K

projected revenue

Competitive Advantages

AI- First Approach

Proprietary neural networks trained on 10,000+ movement patterns

Non- Invasive

Game-​based assessment during natural play

Early Detection

3-5 years before traditional methods

Clinical Validation

Partnership with leading neurology clinics

Scalable Tech

Cloud-​based with minimal hardware requirements

Current Stage & Milestones

Q1 2024

MVP Completed

Initial clinical trials started with partner institutions

Q2 2024

5 Pilot Installations

Deployed in Estonian clinics and sport centers

Q3 2024

CE Marking Application

Submitted for European medical device certification

Q4 2024

First Commercial Contracts

Signed agreements with healthcare providers

Current

Expanding to 15 Installations

Seeking pre-​seed funding for accelerated growth

2026-2027 Roadmap

Strategic investment allocation for maximum growth

R&D

50%

Algorithm refinement, additional biomarkers, mobile app development

Clinical Consultants

20%

Partnerships with neurologists, clinical trial expansion

Go-​to-​Market

20%

Sales team expansion, marketing campaigns, conference presence

Operations

10%

Infrastructure, compliance, administrative

Investment Opportunity

Round

Pre-​seed

Target

€500K

Valuation

€2M pre-​money

Minimum Investment

€25K

Expected Exit Timeline

5-7 years

Target Exit Multiples

6-10x

Exit Strategy

Strategic Acquisition

Target acquirers:

Medtronic

GE Healthcare

Philips

Siemens

Timeline: 5-7 years | Multiples: 8-12x revenue

Technology Companies

Potential interest from:

Apple Health

Google Health

Microsoft

Timeline: 4-6 years | Multiples: 10-15x revenue

IPO Path

European health-​tech exchanges

Requirements:

• €10M+ revenue
• Strong IP portfolio

Timeline: 7-10 years

Exit Strategy

Strategic Acquisition

Target acquirers:

Medtronic

GE Healthcare

Philips

Siemens

Timeline: 5-7 years | Multiples: 8-12x revenue

Technology Companies

Potential interest from:

Apple Health

Google Health

Microsoft

Timeline: 4-6 years | Multiples: 10-15x revenue

IPO Path

European health-​tech exchanges

Requirements:

• €10M+ revenue
• Strong IP portfolio

Timeline: 7-10 years

Request Investment Materials

Get access to our detailed pitch deck, financial projections, and due diligence documents.

    Traction Metrics

    Active Pilot Sites

    5

    Assessments Completed

    200+

    Diagnostic Accuracy

    94%

    User Satisfaction

    87%

    International LOIs

    3